首页> 外文会议>American Peptide Symposium >SAR Study on CN17p a Potent and Selective CaMKII Peptide Inhibitor
【24h】

SAR Study on CN17p a Potent and Selective CaMKII Peptide Inhibitor

机译:SAR研究CN17P一种有效和选择性Camkii肽抑制剂

获取原文

摘要

Ca~(2+)/Calmodulin-dependent protein kinase II (CaMKII) constitutes a family of kinases that transduces elevated Ca~+ signals in cells to a number of targets [1]. CaMKII regulates diverse cellular functions, including Ca~(2+) homeostasis [2]. Misregulation of this enzyme is involved in cardiovascular diseases including hypertrophy and other types of ischemia/reperfusion injury [3], obesity and diabetes [4]. A natural inhibitor of CaMKII, protein CaM-KIIN and a 27-residue peptide derived from it, (CaM-KNtide, Table 1), are highly selective for inhibition of CaMKII [5]. We have recently demonstrated that a 17-mer peptide (named CN17P) derived from CaM-KNtide still retained useful inhibitory potency (Table 1) [6].
机译:Ca〜(2 +)/钙调蛋白依赖性蛋白激酶II(Camkii)构成一个激酶系列,其将升高的Ca〜+信号转移到细胞中的升高至多个靶标[1]。 Camkii调节不同的细胞功能,包括Ca〜(2+)稳态[2]。这种酶的错误测定参与心血管疾病,包括肥大和其他类型的缺血/再灌注损伤[3],肥胖和糖尿病[4]。均匀抑制蛋白CAM-KIIN和衍生的27-残基肽的天然抑制剂(凸轮轴,表1)是对CAMKII抑制的高度选择性[5]。我们最近证明,来自凸轮轴的17-MEL肽(命名CN17P)仍然保留有用的抑制效力(表1)[6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号